WO2025068850 - METHOD OF TREATING CANCER
National phase entry is expected:
Publication Number
WO/2025/068850
Publication Date
03.04.2025
International Application No.
PCT/IB2024/059228
International Filing Date
23.09.2024
Title **
[English]
METHOD OF TREATING CANCER
[French]
MÉTHODE DE TRAITEMENT DU CANCER
Applicants **
NOVARTIS AG
Lichtstrasse 35
4056 Basel, CH
Inventors
BROBERG, Per Ernst-Uno
Östra Bernadottesgatan 38 A
216 16 Limhamn, SE
FLECK, Juergen Herbert
Kirschenweg 5
79353 Bahlingen, DE
FOLITAR, Ilia
Lichtstrasse 35
4056 Basel, CH
GALETIC, Ivana
Merkursstrasse 33
4123 Allschwil, CH
GERICKE, Germo Hans
Eimeldinger Strasse 9,
79592 Fischingen, DE
KPAMEGAN, Euloge
Novartis Pharmaceuticals Corporation
59 Route 10
East Hanover, New Jersey 07936, US
KOZHUHAROVA, Raya Toteva
ADVANCED ACCELERATOR APPLICATIONS INTERNATIONAL SA
Rue de la Tour I’lle 4
1204 Geneva, CH
MARIANI, Maurizio F.
Advanced Accelerator Applications (Italy)-S.R.L
Via dell'industria Prima Traversa
86077 Pozzilli (Isernia), IT
ELANGUNTHAZATX, Kalidas Menon
ADVANCED ACCELERATOR APPLICATIONS
8-10 Rue Henri Sainte-Claire Deville Cs10150
92500 Rueil-Malmaison, FR
SANTORO, Paola Maria
146 Summer Ave
Reading, Massachusetts 01867, US
SAWHNEY, Amrita Gill
Novartis Pharmaceuticals Corporation, 59 Route 10
East Hanover, New Jersey 07936, US
WEGENER, Antje
78, Rue Guitel
78860 Saint nom la Breteche, FR
Priority Data
63/584,928
25.09.2023
US
63/621,705
17.01.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 5067 | |
| EPO | Filing, Examination | 81936 | |
| Japan | Filing | 588 | |
| South Korea | Filing | 606 | |
| USA | Filing, Examination | 30160 |
Total: 118357 USD
Abstract[English]
- octreotate, as first line therapy.[French]
-octréotate, en tant que première thérapie de première intention.